Solcoseryl Injection 42.5 mg/mL 25 Ampx2 mL

 2,552.00

Manufactured by:
Active Pharmaceutical Ingredient:
Drug Strength: 42.5 mg/mL
Drug Form : Injection
Pack Size : 25 Ampx2 mL
Does this requires a prescription ?Yes

Solcoseryl Injection contains Polidocanol, Inj | belongs to Blood extract

SKU: pg_21461_29724 Categories: ,

Alternate brands

  • Solcoseryl Injection 42.5 mg/mL 3 Ampx2 mL
     309.94
  • You can save 2242.06
  • Solcoseryl Injection 42.5 mg/mL 5 Ampx10 mL
     2,085.00
  • You can save 467

    Reviews

    There are no reviews yet.

    Be the first to review “Solcoseryl Injection 42.5 mg/mL 25 Ampx2 mL”

    How it works

    Solcoseryl Injection 42.5 mg/mL 25 Ampx2 mL increases the formation of blood clots and scar tissue inside the veins and thus immediately helps to shrink the enlarged veins.

    Side effects

    Major & minor side effects for Solcoseryl Injection 42.5 mg/mL 25 Ampx2 mL

    • Bleeding
    • Severe pain, burning, or irritation in legs
    • Discoloration of the skin
    • Severe headache
    • Itching
    • Swelling, warmth, or redness in one or both legs
    • Numbness
    • Dizziness
    • Swelling and redness at the injection site
    • Trouble breathing

    Uses of Solcoseryl Injection 42.5 mg/mL 25 Ampx2 mL

    What is it prescribed for?

    • Varicose veins

      This medicine is used for the treatment of uncomplicated spider veins (varicose veins ≤1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the legs, a condition where the veins become large, twisted and swollen when the vein valves do not work properly.

    Concerns

    Frequently asked questions

    • Onset of action

      The amount of time required for this medicine to show its action is not clinically established.

    • Duration of Effect

      The amount of time for which this medicine remains active in the body is not clinically established.

    • Safe with Alchohol?

      Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

    • Is it habit forming?

      No habit-forming tendencies were reported.

    • Usage in pregnancy?

      This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

    • Usage while breast-feeding?

      This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. If the medicine is used, close monitoring of the infant for any undesired side effects is recommended.

    When not to use?

    • Allergy

      This medicine is not recommended for use if you have a known allergy to Solcoseryl Injection 42.5 mg/mL 25 Ampx2 mL or any other inactive ingredients present along with it.

    • Acute thromboembolic disease

      This medicine is not recommended for use in patients with acute thromboembolic diseases, a condition of formation of blood clot in the blood vessels due to the increased risk of worsening of the patient's condition.

    • Thrombophilia

      This medicine is not recommended for use in patients with thrombophilia (blood coagulation abnormality) due to the increased risk of worsening of the patient's condition.

    Warnings

    Warnings for special population
    • Pregnancy

      This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

    • Breast-feeding

      This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. If the medicine is used, close monitoring of the infant for any undesired side effects is recommended.

    General Warnings
    • Venous thrombosis

      This medicine may cause venous thrombosis (clot formation within a vein) or other thrombotic events and should be used with extreme caution in patients with a history of deep vein thrombosis (clot formation in a deep vein), recent (within 3 months) major surgery, or prolonged hospitalization due to the increased risk for developing a blood clot. Close monitoring of clinical condition, appropriate dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

    • Use in children

      This medicine is not recommended for use in patients less than 18 years of age since the safety and efficacy of use are not clinically established.

    • Anaphylactic reactions

      This medicine may cause severe allergic reactions, including anaphylactic shock in some patients. Appropriate corrective treatments, dose adjustments or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

    • Extravasation

      This medicine has to be administered very carefully to avoid extravasation, as this can cause severe tissue necrosis.

    Dosage

    • Missed Dose

      Since this medicine is administered in the hospital or clinic setting by a qualified healthcare professional, the likelihood of a missed dose is very low.

    • Overdose

      Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.

    Interactions

    Interaction with Medicines
    • Propylene Glycol
    • Peginterferon Alfa-2B

    General Instructions

    This medicine should be administered by a qualified healthcare professional in the clinical or hospital setting. Inform the doctor if you have a known history of allergy to this medicine. Report to the doctor all your current medicines as well as your medical conditions before receiving this medicine. Report any undesirable side effects to the doctor promptly.

    Other details

    • Usage does not depend on food timings
    • To be taken as instructed by doctor
    • Does not cause sleepiness

    References

    Additional Information>

    How to use Solcoseryl Injection 42.5 mg/mL 25 Ampx2 mL

    IV: Administer undiluted. Using a fine-gauge (26 or 30 gauge) needle, insert needle tangentially into affected vein and inject soln slowly while needle is still in vein. Apply only gentle pressure during inj to prevent vein rupture. If repeated treatments are needed, separate by 1- 2 weeks. Following inj, apply compression via stocking or bandage to reduce risk of deep vein thrombosis.

    What happens if I miss a dose of Solcoseryl Injection 42.5 mg/mL 25 Ampx2 mL?

    See literature.

    One of the following licensed pharmacy from the nearest location will deliver Solcoseryl Injection 42.5 mg/mL 25 Ampx2 mL. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

    Questions and Answers

    There are no questions yet. Be the first to ask a question about this product.

    Only registered users are eligible to enter questions

    Medicalstore.com.pk © All rights reserved

    Made with ❤ by Dairah

    Shopping Cart